Brent Tan
Impact in
- Immunology top 5%
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 9
- Viral-associated cancers and disorders 6
- Vascular Tumors and Angiosarcomas 3
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Irving L. Weissman (3 shared papers)Laurie Ailles (1 shared paper)June H. Myklebust (1 shared paper)Charles K. F. Chan (1 shared paper)Feifei Zhao (1 shared paper)Christopher Y. Park (1 shared paper)Javier Briones (1 shared paper)Max Jan (1 shared paper)
- Journals
- American Journal of Clinical Pathology (6 papers)Leukemia Research (2 papers)Journal of Molecular Diagnostics (2 papers)Blood (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- United StatesJapanIndia
In The Last Decade
Brent Tan
24 papers receiving 1.4k citations
Brent Tan's Hit Papers
Peers
Comparison fields: 5 of 91
- Immunology 780
- Oncology 586
- Pathology and Forensic Medicine 222
- Genetics 123
- Hematology 106
Countries citing papers authored by Brent Tan
This map shows the geographic impact of Brent Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent Tan more than expected).
Fields of papers citing papers by Brent Tan
This network shows the impact of papers produced by Brent Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent Tan. The network helps show where Brent Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Brent Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma Hit paper breakdown → | 2010 | 845 |
| 2 | 2006 | 230 | |
| 3 | 2006 | 89 | |
| 4 | 2007 | 71 | |
| 5 | 2011 | 34 | |
| 6 | 2016 | 31 | |
| 7 | 2008 | 26 | |
| 8 | 2020 | 20 | |
| 9 | 2011 | 11 | |
| 10 | 2019 | 9 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 7 | |
| 13 | 2013 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2016 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2022 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2016 | 2 | |
| 20 | 2024 | 2 |
About Brent Tan
Brent Tan is a scholar working on Oncology, Pathology and Forensic Medicine, Hematology, Physiology and Molecular Biology, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (6 papers), Viral-associated cancers and disorders (6 papers), Vascular Tumors and Angiosarcomas (3 papers), Clinical Laboratory Practices and Quality Control (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Histiocytic Disorders and Treatments (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). The work is most often cited by research in Immunology (780 citations), Oncology (586 citations), Pathology and Forensic Medicine (222 citations), Genetics (123 citations) and Hematology (106 citations). Brent Tan has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Irving L. Weissman, Laurie Ailles, June H. Myklebust, Charles K. F. Chan, Feifei Zhao, Christopher Y. Park, Javier Briones, Max Jan, Raquel Malumbres and Saar Gill. Their work appears in journals such as American Journal of Clinical Pathology, Leukemia Research, Journal of Molecular Diagnostics, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.